More NewsRead More
MacroGenics Provides Update on Corporate Progress and First Quarter 2015 Financial Results
May 06, 2015
MacroGenics Presents Pre-Clinical Data on its Multivalent DR5 DART at the AACR Annual Meeting
April 20, 2015
MacroGenics Initiates Phase 1 Study of MGD010 for the Treatment of Autoimmune Disorders
March 16, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here